About Mubadala Capital
Mubadala Capital is a private equity firm founded in 2011. It is primarily based in Abu Dhabi, United Arab Emirates. As of Sep 2026, Mubadala Capital is an active investor with a portfolio of 85 companies, comprising 85 funding rounds and 2 acquisitions. In the last 12 months, it has participated in 7 funding rounds and has made 1 acquisition. The firm primarily invests in companies based in United States and Brazil. Its portfolio is spread across a wide range of sectors from Enterprise Applications to Life Sciences. Its latest investment was a $***** Series D round in Precision Neuroscience on Sep 24, 2026 which also saw participation from PERSHING SQUARE, Duquesne Family Office and other investors.
A lot of funds co-invest with Mubadala Capital, with names like Arch Venture Partners sharing a substantial percentage of its portfolio.
Mubadala Capital has a team of 125 people, including 20 partners.
Key Metrics
Founded Year
2011
Location
Abu Dhabi, United Arab Emirates
Portfolio Sectors
Portfolio Locations
Acquisition Deals
Mubadala Capital's Portfolio
Mubadala Capital has a portfolio of 85 companies. They have invested in a total of 85 companies. Their most recent investment was in Precision Neuroscience (Series D round) on Sep 24, 2026. Here are the most recent investments by Mubadala Capital:Date | Company | Round | Amount | Co-Investors |
|---|---|---|---|---|
Sep 24, 2026 | Series D | 8205 | ||
May 14, 2026 | Series B | 4766 | ||
May 12, 2026 | Series D | 7222 | ||
Mar 31, 2026 | Series E | 9692 |
Mubadala Capital has acquired 2 companies. Their most recent acquisition was of Clear Channel Outdoor on Feb 10, 2026. Here are the most recent acquisitions by Mubadala Capital:
Acquisition Date | Company | Short Description | Total Funding | Founded Year |
|---|---|---|---|---|
Feb 10, 2026 | Provider of outdoor advertising services | - | 1998 | |
Oct 02, 2024 | Provider of data analysis, cyber security management, and digital transformation services | - | 2003 |
Here is the portfolio snapshot of Mubadala Capital:
Investments by Year
The maximum number of investments were made in 2024
Acquisitions by Year
The maximum number of acquisitions were made in 2026
Portfolio by Location
Companies are primarily in United States and Brazil
Portfolio by Sector
Companies are primarily in Enterprise Applications
Team profile of Mubadala Capital
Mubadala Capital has a team of 125 members including 20 Partners and 45 Principals located in United Arab Emirates, United States and 3 more locations. Mubadala Capital's team sits on the board of 1 company.Here is a list of top team members in Mubadala Capital:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | San Francisco | - | ||
Partner | United Arab Emirates | - | ||
Partner | Abu Dhabi | - | - | |
Partner | Katy | - | ||
Partner | United States | - | ||
Partner | San Francisco | - | ||
Partner | San Francisco | - | ||
Partner | United Arab Emirates | - | - | |
Partner | Abu Dhabi | - | ||
Partner | United Arab Emirates | - | ||
Partner | - | - |
Co-investors of Mubadala Capital
Over the past 15 years, 67 investors have co-invested in Mubadala Capital's portfolio companies.
- Top Co-investors of Mubadala Capital: 67 investors entered a company along with Mubadala Capital. These include investors like Arch Venture Partners (3 companies).
Mubadala Capital News
•
•
Crusoe Triples Valuation to $30B With $3B Funding RoundTime News•Sep 04, 2026•Mubadala, Valor Equity Partners, Jane Street, Microsoft and 5 others
•
•
Mubadala Capital Tokenizes Private Markets Fund, Coinbase Takes StakeCoinDesk•Jul 23, 2026•Mubadala Capital
•
•
•
•
Ademi Firm Investigates Clear Channel Outdoor Holdings Transaction with Mubadala Capital and TWG GlobalPR Newswire•Feb 10, 2026•Ademi, Clear Channel Outdoor, JCDecaux, Mubadala and 2 others
•
Alphabet’s robotaxi startup Waymo looks to raise $16B at $110B valuationSiliconAngle•Feb 02, 2026•Waymo, Sequoia Capital, Dragoneer Investment Group, Alphabet and 4 others
•
Juvena Therapeutics Raises $33.5M in Series B FundingFinSMEs•Jan 13, 2026•Juvena Therapeutics, Mubadala Capital, Bison Ventures, Manta Ray Ventures and 2 others
